BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 153962)

  • 1. Spiramycin as a selective dental plaque control agent. Laboratory data.
    Rozanis J; Johnson RH; Haq MS; Schofield ID
    J Periodontal Res; 1979 Jan; 14(1):55-64. PubMed ID: 153962
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of spiramycin on plaque accumulation and gingivitis.
    Johnson RH; Rozanis J; Schofield ID; Haq MS
    Dent J; 1978 Nov; 44(10):456-60. PubMed ID: 365549
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of spiramycin and erythromycin in control of periodontal disease.
    Mills WH; Thompson GW; Beagrie GS
    J Clin Periodontol; 1979 Oct; 6(5):308-16. PubMed ID: 393728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiramycin and the specific plaque hypothesis: a new concept in plaque control.
    Quee TC
    J Can Dent Assoc; 1982 Feb; 48(2):121-7. PubMed ID: 7039775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the clinical efficacy of cefadroxil compared to spiramycin and ampicillin in the treatment of oral infections of dental origin].
    Re G; Prencipe R; Moniaci D; Bertone R
    Minerva Stomatol; 1982; 31(6):825-36. PubMed ID: 6761577
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical therapy of hyperendemic trachoma with rifampicin, oxytetracycline, or spiramycin eye ointments.
    Darougar S; Jones BR; Viswalingam N; Allami J; Minassian D; Farahmandian MA; Houshmand A
    Br J Ophthalmol; 1980 Jan; 64(1):37-42. PubMed ID: 6986898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies of the therapeutic effect of the combination of spiramycin and metronidazole in dental and stomatological diseases].
    Piccione N
    Minerva Stomatol; 1978; 27(3):195-201. PubMed ID: 285333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapeutic treatment of periodontitis with spiramycin].
    Gall E
    SSO Schweiz Monatsschr Zahnheilkd; 1970; 80(7):797-815. PubMed ID: 5269744
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of an alexidine mouthwash on plaque and gingivitis.
    Formicola AJ; Deasy MJ; Graessle OE; Johnson DH; Howe EE
    J Periodontol; 1978 Mar; 49(3):145-7. PubMed ID: 381628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spiramycin].
    Lamy L; Landry RG; Roy S
    J Can Dent Assoc; 1989 May; 55(5):393-5. PubMed ID: 2659147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of spiramycin and doxycycline in the treatment of lower respiratory infections in general practice.
    Biermann C; Løken A; Riise R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():155-8. PubMed ID: 3053569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-blind clinical study of a titrated extract of an unsaponifiable fraction of Zea mays (L) on gingival inflammation].
    Técucianu JF
    Inf Dent; 1975 Jul; 57(27):21-32. PubMed ID: 801827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with the spiramycin-metronidazole combination].
    García Perla A; Gómez de la Mata J
    An Esp Odontoestomatol; 1973; 32(3):239-42. PubMed ID: 4515956
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction in proportions of dental plaque streptococci following a 5 day topical kanamycin treatment.
    Loesche WJ; Hockett RN; Syed SA
    J Periodontal Res; 1977 Jan; 12(1):1-10. PubMed ID: 137306
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind crossover trial on the effect of cetylpyridinium chloride 0.05 per cent (Merocet) on plaque accumulation.
    Llewelyn J
    Br Dent J; 1980 Feb; 148(4):103-4. PubMed ID: 6986884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapeutic control of muco-bacterial plaque in the oral cavity: literature review].
    Martuscelli R; Fusco A; Zarone F
    Arch Stomatol (Napoli); 1983; 24(4):567-76. PubMed ID: 6399670
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of metronidazole and spiramycin in cases of ANUG and mixed oral infection--a double blind clinical trial.
    Miglani DC; Subramanian S; Rajasekher A; Jayanthi S; Paramasivan CN
    J Indian Dent Assoc; 1975 Sep; 47(9):359-68. PubMed ID: 801931
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage.
    Kamme C; Kahlmeter G; Melander A
    Scand J Infect Dis; 1978; 10(2):135-42. PubMed ID: 97775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti calculus and anti plaque agents and their trials.
    Shankwalkar GB
    J Indian Dent Assoc; 1975; Spec Issue():303-10. PubMed ID: 801156
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of the anti-plaque activity of a mucolytic agent, N-Acetyl Cysteine.
    Bowles WH; Goral V
    Dent Hyg (Chic); 1985 Oct; 59(10):454-6. PubMed ID: 3908155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.